Levofloxacine Eg

Levofloxacin, the active ingredient in Levofloxacine Eg, is a fluoroquinolone antibiotic presented as an oral formulation for oral use. It treats bacterial infections such as urinary tract, respiratory, skin and soft‑tissue infections, prostatitis and gonorrhea in adult patients.

GNH USA supplies Levofloxacine Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacin is a broad‑spectrum fluoroquinolone used to treat infections caused by susceptible bacteria in several organ systems. - Urinary tract infections: eradicates uropathogens and relieves dysuria and frequency. - Respiratory tract infections: clears pathogens in bronchitis, sinusitis and community‑acquired pneumonia. - Skin and soft‑tissue infections: resolves cellulitis, abscesses and wound infections. - Prostatitis: eliminates bacterial involvement of the prostate gland. - Gonorrhea: treats uncomplicated Neisseria gonorrhoeae infections.

Levofloxacine Eg may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, occasionally watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Insomnia: difficulty falling or staying asleep. - Rash: mild skin erythema or pruritus.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur during or after therapy. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, angioedema. - Clostridioides difficile infection: colitis with diarrhea. - Peripheral neuropathy: sensory disturbances. - Hepatic dysfunction: elevated liver enzymes or hepatitis.

Levofloxacine Eg requires careful consideration of patient‑specific factors before use. - Renal impairment: dose adjustment may be needed based on renal function. - History of tendon disorders: avoid use in patients with prior tendon injury. - QT prolongation risk: monitor ECG in patients with cardiac disease or electrolyte disturbances. - Concurrent antacids or supplements: separate administration by at least 2 hours to ensure absorption. - Pregnancy and breastfeeding: use only when benefits outweigh potential risks. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Levofloxacine Eg can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: markedly reduce levofloxacin absorption. - Warfarin: potentiates anticoagulant effect, requiring INR monitoring. - Cyclosporine: increases levofloxacin plasma concentrations. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): heighten risk of central nervous system stimulation. - Theophylline: may increase theophylline toxicity.

Moderate Interactions (Monitor Closely): - Diabetes medications: possible alteration of glucose control. - Corticosteroids: increased risk of tendon rupture. - Rifampin: may lower levofloxacin levels, reducing efficacy. - Sulfonylureas: potential for enhanced hypoglycaemia. - Ergot derivatives: risk of vasospasm and ischemia.